130 related articles for article (PubMed ID: 1826751)
1. Correlation between the biological and therapeutic effects of interferon-alpha in low-grade nodular non-Hodgkin's lymphoma: lack of in vivo down-regulation and reduced affinity of IFN-alpha receptors in unresponsive patients.
Billard C; Ferbus D; Diez RA; Kolb JP; Mathiot C; Belanger C; Auzanneau G; Varet B; Falcoff E; Dumont J
Leuk Res; 1991; 15(2-3):121-8. PubMed ID: 1826751
[TBL] [Abstract][Full Text] [Related]
2. In vivo and in vitro induction of 2'-5' oligoadenylate synthetase by interferon-alpha in nodular non-Hodgkin's lymphoma and correlations with the clinical response.
Ferbus D; Khosravi S; Dumont J; Billard C
J Biol Regul Homeost Agents; 1990; 4(4):127-34. PubMed ID: 2096597
[TBL] [Abstract][Full Text] [Related]
3. Growth inhibitory effects of interferon-beta but not interferon-alpha on human glioma cells: correlation of receptor binding, 2',5'-oligoadenylate synthetase and protein kinase activity.
Rosenblum MG; Yung WK; Kelleher PJ; Ruzicka F; Steck PA; Borden EC
J Interferon Res; 1990 Apr; 10(2):141-51. PubMed ID: 2140395
[TBL] [Abstract][Full Text] [Related]
4. Downregulation of interferon alpha but not gamma receptor expression in vivo in the acquired immunodeficiency syndrome.
Lau AS; Read SE; Williams BR
J Clin Invest; 1988 Oct; 82(4):1415-21. PubMed ID: 2971677
[TBL] [Abstract][Full Text] [Related]
5. Action of interferon-alpha on hairy cell leukemia: expression of specific receptors and (2'-5')oligo (A) synthetase in tumor cells from sensitive and resistant patients.
Billard C; Ferbus D; Sigaux F; Castaigne S; Degos L; Flandrin G; Falcoff E
Leuk Res; 1988; 12(1):11-8. PubMed ID: 2965776
[TBL] [Abstract][Full Text] [Related]
6. Alpha-interferon receptors in malignant B-cells from patients with chronic lymphocytic leukemia: relation to induction of 2'-5'-oligoadenylate synthetase and blast transformation.
Ostlund L; Grandér D; Juliusson G; Robèrt KH; Lundgren E; Einhorn S
Cancer Res; 1989 Jun; 49(12):3425-30. PubMed ID: 2524252
[TBL] [Abstract][Full Text] [Related]
7. In vivo sensitivity and resistance of chronic myelogenous leukemia cells to alpha-interferon: correlation with receptor binding and induction of 2',5'-oligoadenylate synthetase.
Rosenblum MG; Maxwell BL; Talpaz M; Kelleher PJ; McCredie KB; Gutterman JU
Cancer Res; 1986 Sep; 46(9):4848-52. PubMed ID: 2942242
[TBL] [Abstract][Full Text] [Related]
8. Binding of human recombinant 125I-interferon gamma to receptors on human cells.
Littman SJ; Faltynek CR; Baglioni C
J Biol Chem; 1985 Jan; 260(2):1191-5. PubMed ID: 3155725
[TBL] [Abstract][Full Text] [Related]
9. Changes in interferon receptors on peripheral blood mononuclear cells from patients with chronic hepatitis B being treated with interferon.
Nakajima S; Kuroki T; Shintani M; Kurai O; Takeda T; Nishiguchi S; Shiomi S; Seki S; Kobayashi K
Hepatology; 1990 Dec; 12(6):1261-5. PubMed ID: 2147916
[TBL] [Abstract][Full Text] [Related]
10. The down-regulation of alpha-interferon receptors in human lymphoblastoid cells: relation to cellular responsiveness to the antiproliferative action of alpha-interferon.
Pfeffer LM; Donner DB
Cancer Res; 1990 May; 50(9):2654-7. PubMed ID: 2139358
[TBL] [Abstract][Full Text] [Related]
11. Proliferative response of hairy cells to B cell growth factor (BCGF): in vivo inhibition by interferon-alpha and in vitro effects of interferon-alpha, -beta, and -gamma.
Genot E; Billard C; Sigaux F; Mathiot C; Degos L; Falcoff E; Kolb JP
Leukemia; 1987 Aug; 1(8):590-6. PubMed ID: 2444836
[TBL] [Abstract][Full Text] [Related]
12. Specific binding of human alpha interferon to high-affinity cell-surface binding sites on peripheral blood mononuclear cells.
Dooley JS; Vergalla J; Hoofnagle JH; Zoon KC; Munson PJ; Jones EA
J Lab Clin Med; 1989 May; 113(5):623-31. PubMed ID: 2523945
[TBL] [Abstract][Full Text] [Related]
13. Down-regulation of peripheral blood cell interferon receptors in chronic myelogenous leukemia patients undergoing human interferon (HuIFN alpha) therapy.
Maxwell BL; Talpaz M; Gutterman JU
Int J Cancer; 1985 Jul; 36(1):23-8. PubMed ID: 3160669
[TBL] [Abstract][Full Text] [Related]
14. Variation in the binding of 125I-labeled interferon-beta ser to cellular receptors during growth of human renal and bladder carcinoma cells in vitro.
Ruzicka FJ; Schmid SM; Groveman DS; Cummings KB; Borden EC
Cancer Res; 1987 Sep; 47(17):4582-9. PubMed ID: 2957045
[TBL] [Abstract][Full Text] [Related]
15. Complete remission following recombinant interferon alpha-2a in a patient with diffuse large B cell cutaneous lymphoma.
Tourani JM; Leaute JB; Lessana-Leibowitch M; Andrieu JM
Nouv Rev Fr Hematol (1978); 1989; 31(4):315-6. PubMed ID: 2691984
[TBL] [Abstract][Full Text] [Related]
16. Immunomodulation by recombinant interferon-alpha 2 in a phase I trial in patients with lymphoproliferative malignancies.
Ozer H; Gavigan M; O'Malley J; Thompson D; Dadey B; Nussbaum-Blumenson A; Snider C; Rudnick S; Ferraresi R; Norred S
J Biol Response Mod; 1983; 2(6):499-515. PubMed ID: 6607323
[TBL] [Abstract][Full Text] [Related]
17. The interaction of interferon-alpha and -gamma: regulation of (2-5)A synthetase activity.
Fish EN; Hannigan GE; Banerjee K; Williams BR
Virology; 1988 Jul; 165(1):87-94. PubMed ID: 2455384
[TBL] [Abstract][Full Text] [Related]
18. Specific residues within an amino-terminal domain of 35 residues of interferon alpha are responsible for recognition of the human interferon alpha cell receptor and for triggering biological effects.
Shafferman A; Velan B; Cohen S; Leitner M; Grosfeld H
J Biol Chem; 1987 May; 262(13):6227-37. PubMed ID: 2952649
[TBL] [Abstract][Full Text] [Related]
19. In vivo and in vitro induction of (2'-5') oligoadenylate synthetase by human interferons in leukocytes from healthy donors and patients with renal cancer and hairy cell leukemia.
Ferbus D; Billard C; Sigaux F; Thang MN; Falcoff E
J Biol Regul Homeost Agents; 1987; 1(3):147-53. PubMed ID: 2459906
[TBL] [Abstract][Full Text] [Related]
20. Treatment of hairy cell leukemia with recombinant alpha interferon: II. In vivo down-regulation of alpha interferon receptors on tumor cells.
Billard C; Sigaux F; Castaigne S; Valensi F; Flandrin G; Degos L; Falcoff E; Aguet M
Blood; 1986 Mar; 67(3):821-6. PubMed ID: 2936410
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
